CAR--话题@MedSci

#CAR-#

459篇内容 | 2609人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781372, encodeId=50a31e813720c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell：重磅，中外团队联合发文，有望设计全新CAR-T疗法, objectType=article, longId=198398, objectId=ab51198398ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab51198398ce, replyNumber=0, likeNumber=155, createdTime=2021-02-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab51198398ce, moduleTitle=Cell：重磅，中外团队联合发文，有望设计全新CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab51198398ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781365, encodeId=4c171e8136563, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议, objectType=article, longId=195728, objectId=ce9d195e287e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce9d195e287e, replyNumber=0, likeNumber=87, createdTime=2021-03-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce9d195e287e, moduleTitle=CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce9d195e287e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781323, encodeId=75651e8132346, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=基于“暗抗原”开发现成的肿瘤疫苗和CAR-T疗法, objectType=article, longId=182841, objectId=acd1182841f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd1182841f6, replyNumber=0, likeNumber=75, createdTime=2020-08-31, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd1182841f6, moduleTitle=基于“暗抗原”开发现成的肿瘤疫苗和CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd1182841f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781315, encodeId=1b9b1e81315a8, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T治疗实体瘤设计策略解析, objectType=article, longId=180812, objectId=6f4e180812b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f4e180812b1, replyNumber=0, likeNumber=95, createdTime=2020-06-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f4e180812b1, moduleTitle=CAR-T治疗实体瘤设计策略解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f4e180812b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781376, encodeId=66411e81376d5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单, objectType=article, longId=198997, objectId=e1ad19899eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ad19899eea, replyNumber=0, likeNumber=81, createdTime=2021-04-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ad19899eea, moduleTitle=国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ad19899eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781374, encodeId=705f1e81374d8, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood重磅｜CAR-NK再度出世，竟比CAR-T细胞免疫疗法更有效？, objectType=article, longId=198778, objectId=f56d198e7883, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56d198e7883, replyNumber=0, likeNumber=80, createdTime=2021-01-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56d198e7883, moduleTitle=Blood重磅｜CAR-NK再度出世，竟比CAR-T细胞免疫疗法更有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f56d198e7883)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781312, encodeId=ea261e81312b2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=首开先河明星抗癌疗法CAR-T能治疗心脏病, objectType=article, longId=179411, objectId=65e01e941182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65e01e941182, replyNumber=0, likeNumber=72, createdTime=2019-12-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65e01e941182, moduleTitle=首开先河明星抗癌疗法CAR-T能治疗心脏病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65e01e941182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781319, encodeId=c3261e81319e6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号, objectType=article, longId=182335, objectId=990d182335ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990d182335ef, replyNumber=0, likeNumber=77, createdTime=2020-10-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990d182335ef, moduleTitle=科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990d182335ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781355, encodeId=f1a31e81355ef, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：KTE-X19 CAR-T细胞治疗难治和复发的套状淋巴瘤，超90%患者应答！, objectType=article, longId=191257, objectId=6a1319125ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a1319125ee2, replyNumber=0, likeNumber=81, createdTime=2021-01-19, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a1319125ee2, moduleTitle=NEJM：KTE-X19 CAR-T细胞治疗难治和复发的套状淋巴瘤，超90%患者应答！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a1319125ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781344, encodeId=c4461e8134404, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cancer Discovery：CAR-T耐药谁之过？T细胞or癌细胞？, objectType=article, longId=187338, objectId=ea1418e33833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea1418e33833, replyNumber=0, likeNumber=54, createdTime=2020-02-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea1418e33833, moduleTitle=Cancer Discovery：CAR-T耐药谁之过？T细胞or癌细胞？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea1418e33833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781321, encodeId=d5df1e813217c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell：新型CAR-T细胞，有望攻克艾滋病, objectType=article, longId=182515, objectId=d3d1182515be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3d1182515be, replyNumber=0, likeNumber=73, createdTime=2020-01-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3d1182515be, moduleTitle=Cell：新型CAR-T细胞，有望攻克艾滋病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3d1182515be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781363, encodeId=6ada1e81363af, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, objectType=article, longId=195407, objectId=8e5719540e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5719540e54, replyNumber=0, likeNumber=120, createdTime=2020-06-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5719540e54, moduleTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5719540e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781346, encodeId=cfe81e8134682, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：CAR-NK细胞疗法用于CD19阳性淋巴瘤, objectType=article, longId=187581, objectId=5c3c18e5811a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c3c18e5811a, replyNumber=0, likeNumber=82, createdTime=2020-03-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c3c18e5811a, moduleTitle=NEJM：CAR-NK细胞疗法用于CD19阳性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c3c18e5811a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781330, encodeId=e7ff1e813303a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：死亡受体信号调节CAR-T细胞毒性, objectType=article, longId=184758, objectId=4846184e5845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4846184e5845, replyNumber=0, likeNumber=58, createdTime=2020-05-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4846184e5845, moduleTitle=Blood：死亡受体信号调节CAR-T细胞毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4846184e5845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781354, encodeId=0d8d1e8135466, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞免疫疗法（idecabtagene vicleucel）治疗多发性骨髓瘤, objectType=article, longId=191240, objectId=fac619124043, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fac619124043, replyNumber=0, likeNumber=112, createdTime=2020-06-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fac619124043, moduleTitle=CAR-T细胞免疫疗法（idecabtagene vicleucel）治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fac619124043)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781318, encodeId=d3591e8131883, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell:艾滋病研究重大成果：CAR-T免疫疗法显著减少HIV感染！, objectType=article, longId=182015, objectId=2fb2182015de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fb2182015de, replyNumber=0, likeNumber=85, createdTime=2020-01-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fb2182015de, moduleTitle=Cell:艾滋病研究重大成果：CAR-T免疫疗法显著减少HIV感染！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fb2182015de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781335, encodeId=8d721e8133575, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=2019 ASH -- 陆佩华院长分享CAR-T细胞免疫治疗新成果, objectType=article, longId=184995, objectId=1b4d18499539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b4d18499539, replyNumber=0, likeNumber=68, createdTime=2020-09-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b4d18499539, moduleTitle=2019 ASH -- 陆佩华院长分享CAR-T细胞免疫治疗新成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b4d18499539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781329, encodeId=a8311e813295d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature Biomedical Engineering：为CAR-T装备“盔甲”，消灭实体瘤不是梦！, objectType=article, longId=184735, objectId=776e184e359f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=776e184e359f, replyNumber=0, likeNumber=92, createdTime=2020-09-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776e184e359f, moduleTitle=Nature Biomedical Engineering：为CAR-T装备“盔甲”，消灭实体瘤不是梦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776e184e359f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781343, encodeId=7d1c1e81343ef, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤, objectType=article, longId=187285, objectId=d73e18e28514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d73e18e28514, replyNumber=0, likeNumber=109, createdTime=2020-10-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d73e18e28514, moduleTitle=欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d73e18e28514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781341, encodeId=5b561e813414e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=新上市的BioNTech收购Neon以增强其CAR-T和TCR-T细胞治疗管线, objectType=article, longId=186503, objectId=f6d21865035f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d21865035f, replyNumber=0, likeNumber=60, createdTime=2020-10-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d21865035f, moduleTitle=新上市的BioNTech收购Neon以增强其CAR-T和TCR-T细胞治疗管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d21865035f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell：重磅，中外团队联合发文，有望设计全新CAR-T疗法

2021-02-28

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议

2021-03-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

基于“暗抗原”开发现成的肿瘤疫苗和CAR-T疗法

2020-08-31

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T治疗实体瘤设计策略解析

2020-06-04

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

国产创新药迎来高光时刻！CAR-T疗法拟纳入突破性治疗药物名单

2021-04-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Blood重磅｜CAR-NK再度出世，竟比CAR-T细胞免疫疗法更有效？

2021-01-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

首开先河明星抗癌疗法CAR-T能治疗心脏病

2019-12-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

科济生物CAR-T细胞疗法治疗复发或难治性多发性骨髓瘤，被FDA授予再生医学先进疗法称号

2020-10-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：KTE-X19 CAR-T细胞治疗难治和复发的套状淋巴瘤，超90%患者应答！

2021-01-19

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cancer Discovery：CAR-T耐药谁之过？T细胞or癌细胞？

2020-02-24

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell：新型CAR-T细胞，有望攻克艾滋病

2020-01-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解

2020-06-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：CAR-NK细胞疗法用于CD19阳性淋巴瘤

2020-03-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Blood：死亡受体信号调节CAR-T细胞毒性

2020-05-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞免疫疗法（idecabtagene vicleucel）治疗多发性骨髓瘤

2020-06-02

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell:艾滋病研究重大成果：CAR-T免疫疗法显著减少HIV感染！

2020-01-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

2019 ASH -- 陆佩华院长分享CAR-T细胞免疫治疗新成果

2020-09-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature Biomedical Engineering：为CAR-T装备“盔甲”，消灭实体瘤不是梦！

2020-09-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

欧洲药品管理局开始审查Kite的自体CAR-T细胞疗法KTE-X19，用于治疗套细胞淋巴瘤

2020-10-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

新上市的BioNTech收购Neon以增强其CAR-T和TCR-T细胞治疗管线

2020-10-24

科室
- - 订阅+
  - 更多科室
工具
服务